Significance of 18F-Fluorodeoxyglucose (FDG) Uptake in Response to Chemoradiotherapy for Pancreatic Cancer

Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma

(2018) Hiroshi Kurahara et al.   ANNALS OF SURGICAL ONCOLOGY

Use of count-based image reconstruction to evaluate the variability and repeatability of measured standardised uptake values

(2018) Tomohiro Kaneta et al.   PLoS One

18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma

(2017) Kyohei Ariake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

(2017) Margaret A. Tempero et al.   Journal of the National Comprehensive Cancer Network

Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients

(2017) Gaowa Sharen et al.   Oncotarget

Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy

(2016) Eric A. Mellon et al.   ACTA ONCOLOGICA

Positron emission tomography response evaluation from a randomized phase III trial of weeklynab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas

(2016) R. K. Ramanathan et al.   ANNALS OF ONCOLOGY

Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer

(2016) Hidenori Takahashi et al.   ANNALS OF SURGERY

Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer

(2016) W. Hartwig et al.   BRITISH JOURNAL OF SURGERY

The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients

(2016) Hayato Kaida et al.   EUROPEAN JOURNAL OF RADIOLOGY

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

(2016) Pascal Hammel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma

(2016) Ashley H. Davis-Yadley et al.   PANCREAS

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer

(2015) Si Shi et al.   CANCER LETTERS

Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo

(2015) Xing-Mei Luo et al.   PLoS One

Role of SUVmax obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion

(2013) Si-Long Hu et al.   NUCLEAR MEDICINE COMMUNICATIONS

Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

(2012) T. W. H. Meijer et al.   CLINICAL CANCER RESEARCH

Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer

(2011) Hidenori Takahashi et al.   ANNALS OF SURGERY

A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer

(2011) Hiroyuki Shinchi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

(2010) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

Apigenin Down-Regulates the Hypoxia Response Genes: HIF-1α, GLUT-1, and VEGF in Human Pancreatic Cancer Cells

(2010) Laleh G. Melstrom et al.   JOURNAL OF SURGICAL RESEARCH

The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes

(2010) A. J. Levine et al.   SCIENCE

A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer

(2009) Saila P. Kauhanen et al.   ANNALS OF SURGERY

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

(2008) William Small et al.   JOURNAL OF CLINICAL ONCOLOGY

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

(2008) S. Jones et al.   SCIENCE